Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alfuzosin Sexual Function Study in BPH
NCT00542165Phase 4Completed
- Sponsor
- Sanofi
- Start
- Mar 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alfuzosin in benign prostatic hyperplasia (BPH), sponsored by Sanofi. Started Mar 2004; status: completed.
02
Drugs
alfuzosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT00542165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00542165.